Introduction: Open repair of ruptured abdominal aortic aneurysm (rAAA) still has a high mortality. Endovascular aortic repair (EVAR) may be the way to improve survival rates. However, it is not clear how many patients with rAAA will be suitable for acute EVAR. Methods: Between October 2000 and April 2002 all patients with acute symptomatic or ruptured AAA were assessed for EVAR on an intention-to-treat basis with emergency computed tomographic angiography (CTA). Patient and logistic characteristics were analysed. We used two commercially available aorto uni-iliac devices with a maximum proximal diameter of 28 and 34 mm. Results: Five out of 26 patients were excluded for CTA and EVAR because of severe and persistent hypotension (3 pts) or logistic reasons (2 pts, both eligible). Twelve patients were found not eligible for EVAR due to unsuitable infrarenal aortic neck length (3 pts), neck diameter (1 pt) or a combination of both (8 pts). The remaining six patients were treated with EVAR. After 6 months no graft failure or aneurysm related deaths were recorded in the EVAR group. Conclusion: A total of 28% of patients with symptomatic or ruptured AAA was treated with EVAR. A potential 42% of patients could have been suitable for EVAR, if the correct devices had been in stock and all patients had been properly assessed.
Introduction
Basic surgical techniques and outcome for ruptured abdominal aortic aneurysm (rAAA) repair have changed little during the last decades. Despite improved intra and postoperative care, rAAA still has a poor prognosis with an excessive hospital mortality estimated as high as 41% 1 with significant associated morbidity. This is in accordance with our own figures; the yearly mortality in our hospital during the last 5 years of open repair for rAAA varied between 33 and 55%.
Endovascular aortic repair (EVAR) in elective abdominal aortic aneurysm (AAA) surgery has proven to be technically feasible and safe with interesting improvements in short-term outcome. 2, 3 We have a 5year experience with elective EVAR in more than 100 patients. No major events have taken place in the follow-up, i.e. no aneurysm rupture or graft related mortality. Our hospital mortality in elective EVAR is 1.8%.
In search of techniques to improve the persistent moderate results of open rAAA repair acute EVAR could have potential advantages. It avoids major surgical exposure and can be performed under local anaesthesia with less physical stress and minimal blood loss. 4 -6 We started a study in which patients with acute symptomatic AAA (sAAA) or rAAA were assessed for EVAR. The main objective was to investigate what number of patients was eligible for EVAR applying our strict anatomic criteria for elective EVAR using an aorto uni-iliac (AUI) endograft with a contra-lateral occluder and femorofemoral cross-over bypass.
Methods
During an 18-month period (October 2000 -April 2002) all consecutive patients presenting with the clinical diagnosis of acute sAAA or rAAA at the Accident and Emergency Department (AED) of our hospital were assessed for possible emergency EVAR on base of an intention-to-treat protocol. Approval of this protocol by the local ethics committee was obtained. The in-and exclusion criteria are described in Table 1 . Resuscitation with limited fluid infusion and even nitroprusside was performed to keep the systolic blood pressure stable around 80 mmHg until the aneurysm was excluded. Unstable patients with persistent systolic blood pressure lower than 80 mmHg, indicating a free intra-abdominal rupture of the aneurysm, were excluded for computed tomographic angiography (CTA) and consequently for EVAR in this study.
Patient characteristics, risk factors and co-morbidity according to the Society for Vascular Surgery/North American Chapter of the International Society for Cardiovascular Surgery (SVS/ISCVS), spiral CTA measurements, elapsed time between admission and start of operation, logistics, and intra-and postoperative course of the EVAR cohort were recorded. Characteristics and outcome of EVAR and open repair for rAAA were compared.
After emergency clinical assessment at the AED, the patient was immediately transferred for CTA of the abdominal aorta and iliac vessels. In the first run, plain 8 mm slices of the descending aorta and iliac arteries were made. If the diagnosis of (ruptured) AAA was confirmed and EVAR seemed applicable, 100 ml (2.5 ml/s) of intravenous contrast (Visapaquee 320, Amersham cygne BV, Eindhoven, The Netherlands) was administered. Thirty seconds after contrast infusion 4 mm slices were made of the abdominal aorta and the iliac arteries to assess the exact morphology of the aneurysm. The total scanning time was less then 10 min. The plain and contrast enhanced CTA were reviewed 'online' by a vascular surgeon and an interventional radiologist. Our anatomical selection criteria used for elective EVAR were also used for emergency EVAR (Table 2 ).
Immediately after the scan was performed, the patient was transported to the operating suite. The patient was prepared and draped for a potential emergency abdominal approach.
At the beginning of this study only the AneuRx AUI (Medtronic AVE, Santa Rosa, CA, USA) was available (maximum diameter of the main body of 28 mm), which is suitable for a maximum neck diameter of the aneurysm of 25 mm. During the last 6 months of the study the so-called Talent emergency AUI kit (Medtronic AVE, Santa Rosa, CA, USA) with a bare suprarenal fixation spring became available (maximum diameter of the main body 34 mm), stretching the maximum acceptable neck diameter of the aneurysm to 30 mm. 7 The EVAR procedure was started with a femoral cutdown on both sides. The common femoral artery was exposed. If the blood pressure decreased below 50 mmHg a supracoeliac aortic occlusion balloon was introduced via the contra-lateral femoral artery. The AUI stent was introduced via the femoral artery up to the level of L1 over a stiff wire (Back-up Meier 185 cm, 0.89 mm, Boston Scientific, Miami, FL, USA), in the Iliac arteries 1. Suitable for access of main delivery system on ipsilateral side 2. Suitable for sealing and fixation on ipsilateral side at the level of the common or the external iliac artery. 3. Suitable for common iliac artery occlusion on the contra-lateral side contra-lateral femoral artery a straight flush catheter (Soft VU Straight flush 5F, 65 cm, Angiodynamics, Queenbury, NY, USA) was introduced and also placed at the level of L1. The first angiography was then performed visualizing the renal arteries. The proximal 4 cm of the AUI was deployed and the upper part of the covered graft was pulled down and positioned exactly below the most distal renal artery. This position was assessed with a second angiogram. Thereafter the main body was deployed completely; the straight flush catheter was pulled back into the distal aorta and the sealing areas were ballooned if appropriate. An ipsilateral iliac extension was placed when sealing and fixation in the common iliac artery area seemed insufficient. In case of the Talent 2-part stent graft the limb was placed in the proximal device component. The contra-lateral common iliac artery was marked with the straight flush catheter and thereafter occluded using an occlusion device. After the stent graft was expanded, an angiogram was made to confirm the appropriate position of the graft and complete exclusion of the rAAA. The procedure was completed with revascularisation of the contra-lateral leg with a 6 or 8 mm femorofemoral cross-over tube graft. A CTA was planned on the fifth postoperative day.
Results
A total of 26 patients presented with the clinical diagnosis of rAAA (25 pts) or acute symptomatic AAA (1 pt) ( Fig. 1 ). The characteristics on admission of these 26 patients are scheduled in Table 3 . In five patients CTA was not performed; three patients were hemodynamically unstable on admission and had an emergency laparotomy without delay, one patient was not included because the endovascular team was not notified and in one patient the appropriate endovascular device was out of stock. While performing open repair we observed that EVAR would have been possible in these last two patients with both devices. Emergency CTA evaluation was performed in the remaining 21 patients. In 20 patients the diagnosis contained that rAAA was confirmed; one patient had a symptomatic AAA with contrast filled tears in the thrombus. The CTA characteristics of the aneurysm are listed in Table 4 . A total of six patients were accepted for emergency EVAR. The AneuRx AUI stent graft was used in five patients and the Talent AUI stent graft in one. The remaining 12 patients were not eligible for EVAR due to infrarenal aortic neck length (3 pts), infrarenal aortic neck diameter (1 pt) or a combination of neck length and neck diameter (8 pts). Two of these 12 patients were not treated because of severe cardiopulmonary co-morbidity. All aneurysms were excluded successfully and no endoleaks were detected at the end of the EVAR procedures.
We encountered serious intra-operative hemodynamic problems in the two EVAR patients treated under general anaesthesia, whereas the next four EVAR patients treated under local anaesthesia had no problems. Postoperatively these two patients needed prolonged artificial ventilator support due to high intra-abdominal pressure, which was monitored by measuring the urinary bladder pressure. 8 In one of these patients a large intra-abdominal haematoma caused an abdominal compartment syndrome with increased pulmonary peak pressure, oliguria and urinary bladder pressure above 20 cm H 2 O. We performed a laparotomy on the first postoperative day to evacuate the intra-abdominal haematoma. Unfortunately this did not immediately improve his condition. The patient was weaned from ventilatory support on the 19th postoperative day. This patient died unexpectedly the day before discharge (30th postoperative day) due to cardiac arrhythmia. There was a clear tendency to diminished blood loss and blood replacement, ICU stay, hospital stay, and mortality in the EVAR group (Table 5 ). On CTA before discharge one patient had a small type 2 endoleak from a lumbar artery, the other aneurysms were excluded completely.
Six to 24 months of follow-up is available in the five surviving EVAR patients ( Table 6 ). The diameter (D3) of the AAAs was stable (1 pt with type 2 lumbar endoleak) or clearly decreased (4 pts). One additional endovascular procedure was necessary to exclude a growing iliac aneurysm. One patient died due to pulmonary insufficiency not related to the aneurysm 8 months postoperatively.
Discussion
Using our strict criteria for EVAR for the AneuRx AUI stent graft 24% of the patients with acute sAAA or rAAA were suitable for EVAR. This figure is considerably lower than cited in some publications, 9 but we emphasize that the group in this study is an unselected group. There was only one referred patient, who had a juxtarenal aneurysm. This is demonstrated by the fact that the number of patients with sAAA or rAAA that was suitable for EVAR corresponds with the number of elective patients that is suitable for EVAR in our hospital using an AneuRx bifurcation endograft. A potential 11 out of 26 patients (42%) presenting with sAAA or rAAA could have been eligible for EVAR with the Talent AUI emergency kit, an AUI device with a largest proximal diameter of 34 mm. A majority of patients were not suitable for EVAR due to an inappropriate aortic neck length. Consequently, further enlarging the proximal graft diameter will not importantly increase the amount of patients suitable for EVAR. In our opinion further reducing the minimal acceptable aortic neck length for acute EVAR below 8 mm will significantly increase the chance of proximal type 1 endoleak on short term. This type 1 endoleak will result in persistent bleeding in an unstable patient. Conversion to open repair is a hazardous procedure as it is accompanied by an increased mortality, even in elective patients. 10 In all rAAA and sAAA patients we used an aorto uni-iliac system with femorofemoral cross-over graft. The introduction and deployment of an AUI device is rapid and relatively simple, leading to a swift exclusion of the bleeding aneurysm. In our experience with EVAR in elective AAA patients the cannulation of the contra-lateral gate is possible within 5 min in a fast majority of the patients. However, in 16% of our elective EVAR procedures the cannulation time exceeds 20 min, which can result in prolonged bleeding in unstable patients with rAAA. Therefore an AUI device is the appropriate choice in patients with rAAA.
The number of patients presented here are small and no statistical claims can be made. However, the mortality in the EVAR group was remarkably low 17% (1/6). The exclusion of the rAAA was clinically successful in all patients. We only had one type 2 endoleak in the EVAR group not needing endovascular exclusion so far. Although these figures make emergency EVAR interesting we also encountered new problems.
Firstly, two patients had prolonged respiratory problems due to abdominal compartment syndrome caused by a large intra-abdominal and retroperitoneal haematoma. This is probably due to relaxation of abdominal muscle tone in general anaesthesia with subsequent free intraperitoneal rupture of the contained rAAA. Swift exclusion of the aneurysm and/or the use of an occlusion balloon can prevent excessive bleeding. Local or locoregional anaesthesia seems preferable instead of general anaesthesia. 6 Another option could be to start with local anaesthesia until the aneurysm is excluded, and then continuing the procedure under general anaesthesia. 7 Measuring urinary bladder pressure can assess intra-abdominal pressure. If the intra-abdominal pressure is higher than 20 cm H 2 O and there is increased pulmonary peak pressure with oliguria, a laparotomy should be considered to decrease pressure. 8 Secondly, CTA screening of rAAA costs extra time before operation and can impose risks. Scanning time is approximately 10 min, but transport and transfers can cause an extra delay of approximately 15 -20 min. Of course preparing the operation suite takes time as well. We did not encounter adverse effects in our study, but we scanned only patients who were relatively stable.
Thirdly, renal insufficiency can be induced by contrast enhanced CTA and the EVAR procedure. During CTA we administered 100 ml contrast intravenously. During EVAR a mean of 195 ml contrast was used. In our small group of patients we saw only marked increase in creatinine levels postoperatively in two patients, both treated with open surgery and suprarenal clamping of the aorta. There was no renal insufficiency in the EVAR group.
Fourthly, considering logistics we encountered problems in two cases. In one patient the appropriate AneuRx stent grafts were not available, in the second patient the endovascular team was not notified due to unawareness of AED personnel with the EVAR protocol. With the introduction of the so-called Talent emergency kit, the first problem is tackled. All main bodies are compatible with all extensions, thereby reducing the stock that is necessary to treat rAAA, which will also decrease the financial burden. We believe that extensive EVAR protocol training of the AED and operating room personnel including the endovascular team will make EVAR feasible in 40 -50% of the patients with rAAA.
A randomised trial between EVAR and open repair is necessary to demonstrate an improvement in survival of rAAA repair. But even if the rAAAs with the most favourable anatomy are treated with EVAR, the results are thus encouraging 9 that the overall mortality can possibly drop in decades to come and randomised trials may seem unethical. and P. Oude Groothuis (field sales supervisor Medtronic AVE, 
